Gossamer Bio Inc. (GOSS) Tops Q3 EPS by 5c

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q3 EPS of ($0.21), $0.05 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

You May Also Be Interested In

• AI and earnings keep driving markets as focus shifts to Trump-Xi summit
• Gossamer Bio Inc. (GOSS) PT Raised to $90 at H.C. Wainwright
• UBS Reiterates Neutral Rating on Pilgrim's Pride (PPC) on 'Challenging' Near-Term Fundamentals